🔴 BlinkLab is trading 5% down with no confirmed company-specific catalyst

BlinkLab is trading 5.07% lower at A$0.66 on October 1, 2026, with no confirmed company-specific announcement explaining the move.

• Positive European ADHD study results—82% sensitivity and 83% specificity—were reported in August and are prior context, not a clear explanation for the decline.
• The supplied healthcare-sector indicator was down, but the move is not clearly attributable to it. Prior-session volume was 138.11% above its daily average, which does not explain the current drop.